Ownership history in BENDER ROBERT & ASSOCIATES · 20 quarters on record
This page tracks every 13F SEC filing in which BENDER ROBERT & ASSOCIATES reported a position in VERTEX PHARMACEUTICALS INC (VRTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 26,463 | +133 | +0.5% | 2.49% | $12.0M | $453.36 |
| 2025 Q3 | REDUCED | 26,330 | -382 | -1.4% | 2.23% | $10.3M | $391.64 |
| 2025 Q2 | REDUCED | 26,712 | -313 | -1.2% | 2.65% | $11.9M | $445.20 |
| 2025 Q1 | REDUCED | 27,025 | -281 | -1.0% | 3.31% | $13.1M | $484.82 |
| 2024 Q4 | ADDED | 27,306 | +172 | +0.6% | 2.65% | $11.0M | $402.70 |
| 2024 Q3 | REDUCED | 27,134 | -154 | -0.6% | 2.68% | $12.6M | $465.08 |
| 2024 Q2 | REDUCED | 27,288 | -884 | -3.1% | 2.81% | $12.8M | $468.72 |
| 2024 Q1 | REDUCED | 28,172 | -378 | -1.3% | 2.76% | $11.8M | $418.01 |
| 2023 Q4 | ADDED | 28,550 | +96 | +0.3% | 2.93% | $11.6M | $406.89 |
| 2023 Q3 | ADDED | 28,454 | +47 | +0.2% | 2.89% | $9.9M | $347.74 |
As of 2025 Q4 — sorted by position size